Related references
Note: Only part of the references are listed.Brain MRI Lesion Load at 1.5T and 3T versus Clinical Status in Multiple Sclerosis
James M. Stankiewicz et al.
JOURNAL OF NEUROIMAGING (2011)
Black holes in multiple sclerosis: definition, evolution, and clinical correlations
M. A. Sahraian et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Tissue-Specific Imaging Is a Robust Methodology to Differentiate In Vivo T1 Black Holes with Advanced Multiple Sclerosis-Induced Damage
M. Riva et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
The Pathologic Substrate of Magnetic Resonance Alterations in Multiple Sclerosis
Hans Lassmann
NEUROIMAGING CLINICS OF NORTH AMERICA (2008)
The effect of varying echo spacing within a multiecho acquisition:: better characterization of long T2 components
Matthew G. Skinner et al.
MAGNETIC RESONANCE IMAGING (2007)
The effect of IFN-β on black holes in patients with multiple sclerosis
Francesca Bagnato et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis
F Bagnato et al.
JOURNAL OF NEUROVIROLOGY (2005)
Optimizing brain tissue contrast with EPI: A simulated annealing approach
VN Ikonomidou et al.
MAGNETIC RESONANCE IN MEDICINE (2005)
Remyelinated lesions in multiple sclerosis -: Magnetic resonance image appearance
F Barkhof et al.
ARCHIVES OF NEUROLOGY (2003)
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years
F Bagnato et al.
BRAIN (2003)
Accurate, robust, and automated longitudinal and cross-sectional brain change analysis
SM Smith et al.
NEUROIMAGE (2002)
Rapid method for correction of CSF partial volume in quantitative proton MR spectroscopic imaging
A Horská et al.
MAGNETIC RESONANCE IN MEDICINE (2002)
The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS
PA Brex et al.
NEUROLOGY (2001)
Glatiramer acetate reduces the proportion of new MS lesions evolving into black holes
M Filippi et al.
NEUROLOGY (2001)
A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions
A Bitsch et al.
ANNALS OF NEUROLOGY (2001)
T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study
M Sailer et al.
EUROPEAN JOURNAL OF NEUROLOGY (2001)
Share Paper
